The pharmacokinetic of chlorpheniramine of two formulations (Contac (r) (Wellcome, United Kingdom) and Vietnamese formulation) of racemic chlorpheniramine combined with phenylpropanolamine, was assessed in an open-labelled, randomized, crossover two-period study, after administration of 8 mg of racemic chlorpheniramine in 12 healthy Vietnamese subjects.